HK Inno.N Corp (195940)

Currency in KRW
34,250
-400(-1.15%)
Closed·
195940 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
33,70035,300
52 wk Range
32,60058,600
Key Statistics
Bid/Ask
33,850.00 / 33,900.00
Prev. Close
34,650
Open
34,650
Day's Range
33,700-35,300
52 wk Range
32,600-58,600
Volume
87.74K
Average Volume (3m)
112.01K
1-Year Change
-30.668%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
195940 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
61,083
Upside
+78.35%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a poor free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Analyst Ratings

12 Buy
0 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 61,083
(+78.35% Upside)

Earnings

Latest Release
Oct 28, 2026
EPS / Forecast
-- / 594,00
Revenue / Forecast
260,4B / 270,98B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -
Dividend Yield
1.18%
Industry Median 1.30%
Annualised payout
410.00
Paid annually
5-Years Growth
-
Growth Streak

195940 Income Statement

Compare 195940 to Peers and Sector

Metrics to compare
195940
Peers
Sector
Relationship
P/E Ratio
0.0x−3.8x−0.3x
PEG Ratio
0.000.020.00
Price/Book
0.0x0.7x2.6x
Price / LTM Sales
0.0x0.5x2.8x
Upside (Analyst Target)
78.3%144.2%66.6%
Fair Value Upside
Unlock32.3%9.1%Unlock

HK inno.N Corporation engages in the pharmaceutical business in South Korea. The company offers prescription drugs for the treatment of gram-positive and gram-negative organisms, enterococcus faecium infections, vancomycin-resistant, acute bacterial sinusitis, bronchitis, neumonia, antibiotics, and infections caused by microorganism; anemia and hemodialysis; diabetes; hypertension, primary hypercholesterinemia, homozygous familial hypercholesterolemia, and hypertension with dyslipidemia; GERD, EE, NERD, GU and H.Pylori; pleural mesothelioma, non-small cell lung cancer, and mesothelioma, and colorectal cancer; and nutrition and intravenous nutrition. It also provides health and beverage products, such as hangover relief, ready to drink, health supplements and health functional foods, as well as active pharmaceutical ingredients. In addition, the company offers beauty products under the bewants, ScalpMed, and KLEDERMA RX brands. It also exports its products to Japan, Southeast Asia, Latin America, Europe, and the Middle East countries. The company has joint research and development agreement with Nextgen Bioscience for NXC680, a candidate compound for treatment of Idiopathic Pulmonary Fibrosis. HK inno.N Corporation was founded in 1984 and is headquartered in Cheongju-si, South Korea.

Employees
1695

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1,84M6,48%62,85B
Other Institutional Investors
16,13M56,94%552,50B
Public Companies & Retail Investors
10,36M36,58%354,95B
Total
28,33M100,00%970,3B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Kolmar Korea Co., Ltd.43,01%12 185 999417 370 466
The National Pension Fund5,03%1 425 59348 826 560

FAQ

What Is the HK Inno.N (195940) Stock Price Today?

The HK Inno.N stock price today is 34 250 KRW.

What Stock Exchange Does HK Inno.N Trade On?

HK Inno.N is listed and trades on the KOSDAQ.

What Is the Stock Symbol for HK Inno.N?

The stock symbol for HK Inno.N is "195940."

What Is the HK Inno.N Market Cap?

As of today, HK Inno.N market cap is 970,3B KRW.

When Is the Next HK Inno.N Earnings Date?

HK Inno.N will release its next earnings report on Feb 16, 2027.

From a Technical Analysis Perspective, Is 195940 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has HK Inno.N Stock Split?

HK Inno.N has split 0 times.

How Many Employees Does HK Inno.N Have?

HK Inno.N has 1695 employees.

What is the current trading status of HK Inno.N (195940)?

As of Oct 31, 2026, HK Inno.N (195940) is trading at a price of 34 250 KRW, with a previous close of 34 650 KRW. The stock has fluctuated within a day range of 33 700 KRW to 35 300 KRW, while its 52-week range spans from 32 600 KRW to 58 600 KRW.

What Is HK Inno.N (195940) Price Target According to Analysts?

The average 12-month price target for HK Inno.N is 61 083 KRW, with a high estimate of 70000 KRW and a low estimate of 52000 KRW. 12 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +78,35% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.